CCCC
C4 Therapeutics Inc
3.00$
-1.6%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -277.3% | -736.2% | -596.2% | -41.4% | -157.1% | -346.4% | -459.9% | -186.6% | -277.9% | -201.0% | -486.7% | -23.7% | -242.2% | |
| 4.0% | 51.9% | 14.7% | 3.7% | 2.9% | 9.3% | 6.3% | 9.5% | 4.1% | 3.9% | 6.6% | 48.0% | 12.8% | |
| 74.1% | 195.0% | 204.5% | 53.1% | 57.5% | 159.1% | 76.1% | 77.2% | 40.9% | 36.4% | 43.4% | 45.7% | 40.8% | |
| -121.9% | 104.4% | 110.5% | 48.9% | -58.6% | 143.4% | -190.9% | 112.1% | -142.7% | -60.6% | -134.5% | 262.8% | -38.6% | |
| 5.4% | 4.8% | 0.0% | 1.6% | 0.1% | 0.1% | 0.0% | 2.9% | 3.7% | 0.1% | 1.0% | 0.6% | 1.5% | |
| 521.4% | 979.6% | -1,757.0% | -97.5% | 1.1% | 264.1% | 402.4% | 602.2% | 36.4% | -732.9% | 262.6% | -223.1% | -214.9% | |
| -0.1% | 0.0% | -3.6% | 0.0% | -0.6% | 0.0% | -2.1% | 0.0% | -0.2% | -0.1% | -3.3% | 0.0% | -0.7% | |
| – | – | – | – | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| -97.1% | 1,768.5% | 1,138.0% | 1.1% | 68.4% | 2.2% | -0.6% | 0.0% | 69.2% | 1,077.3% | 7.5% | 507.8% | 458.4% | |
| 146.9% | 2,012.2% | -1,215.2% | -137.8% | -87.7% | -80.2% | -58.1% | 415.7% | -172.3% | 143.4% | -216.7% | 261.0% | 1.3% | |
| -282.8% | -741.1% | -596.2% | -43.1% | -157.0% | -346.3% | -459.9% | -189.4% | -281.5% | -201.1% | -487.8% | -24.3% | -243.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.